January-February 2025
Interventions and Assessments
- Semaglutide and Liraglutide Associated with Reduction in Alcohol and Substance Use Disorder-related Hospitalizations
- Long-acting Injectable Naltrexone and Buprenorphine-naloxone Well-tolerated in Youth With Opioid Use Disorder One Month Post-initiation
Health Outcomes
- Methadone Remains Superior to Buprenorphine for Opioid Use Disorder Treatment Retention, Even as Fentanyl Dominates the Drug Supply
- Factors Associated With Return to Alcohol Use Following Liver Transplant
- Characterizing Xylazine-associated Wounds
- Wounds Attributed to Xylazine Exposure Are Associated With Subcutaneous Injection Drug Use and Healthcare Stigma
- Prenatal Cannabis Exposure Modestly Associated With Decreased Birth Weight